Pro-ficiency Acquires Fugitive Labs

July 12, 2022

Pro-Ficiency Acquires Fugitive Labs

DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) — Pro-ficiency announces the acquisition of all life sciences intellectual property and the associated team of Fugitive Labs, a full-service nationwide product development firm. This acquisition significantly increases Pro-ficiency’s platform and product development capabilities, which will serve to increase the organization’s competitive advantage in clinical trials performance management. The expanded development team will foster Pro-ficiency’s ability to deliver on a robust development pipeline for years to come. 

“The Fugitive team is an incredible addition for us,” said Pro-ficiency CEO, Michael Raymber. “It’s rare to find a product team that understands clinical trials and also develops beautiful, simple, and highly functional user experiences. To have the Fugitive team fully dedicated to innovation within Pro-ficiency is going to keep us lightyears ahead of others in our space.”

The Fugitive Labs team is led by Erik Guffrey, Fugitive Labs CEO, now Pro-ficiency Chief Technology Officer. Mr. Guffrey brings a team of product developers with him to focus on building and enhancing the Pro-ficiency suite of products and services. 

“What Pro-ficiency is doing to evolve performance in clinical trials is truly unique and exciting,” said Erik Guffrey, Pro-ficiency’s new Chief Technology Officer. “This team (at Pro-ficiency) is relentless about thinking differently to address problems for study teams and learners at the site. Having the resources, creative support and collaborative approach with a leadership team like this is a dream situation for any developer. We can make magic happen.”

Included in the acquisition of Fugitive Labs is a collection of ready-made platforms built specifically for clinical trial use and tested with major CROs and sponsors. 

The acquisition marks the first for Pro-ficiency since their funding by NovaQuest Private Equity in 2021. Rollout plans for the acquired platforms and newly developed services will be announced in future press releases. 

About Fugitive Labs:

The Fugitive Labs core team includes a focused group of designers, engineers, and strategists skilled at combining rapid prototyping toward MVP (Minimum Viable Product) with the long-term product vision needed to achieve scale. Their areas of expertise include web and mobile development, API development, user experience, interface design and interaction design. 

About Pro-ficiency:

Pro-ficiency is a leading provider of simulation-based training and compliance solutions for clinical trials. The Company provides a comprehensive suite of services, including turn-key customized, virtual training simulations, training and compliance monitoring tools, and real-time data & predictive analytics. Learn more at pro-ficiency.com.


Collin Brooks, Marketing Manager

collin.brooks@pro-ficiency.com, +1 919.909.0420